These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6762480)

  • 21. Slow release theophylline in patients with airways obstruction with particular reference to the effects of food upon serum levels.
    Thompson PJ; Kemp MW; McAllister WA; Turner-Warwick M
    Br J Dis Chest; 1983 Jul; 77(3):293-8. PubMed ID: 6351891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Obstructive lung diseases. Efficient therapy using Phyllotemp retard].
    Vorberg G
    ZFA (Stuttgart); 1979 Feb; 55(6):397-9. PubMed ID: 419830
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G
    Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases].
    Nolte D; Dusik B
    Fortschr Med; 1983 Jul; 101(25):1203-6. PubMed ID: 6884955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
    Wiesner B; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tolerability of a new oral controlled release theophylline preparation in patients with obstructive airways diseases.
    Nolte D; Dusik B
    Br J Clin Pract Suppl; 1984; 32():18-21. PubMed ID: 6432018
    [No Abstract]   [Full Text] [Related]  

  • 27. [Theophylline therapy in obstructive respiratory diseases. 1. Bioavailability and pharmacokinetics of various theophylline preparations (author's transl)].
    Wemhöner S; Oellerich M; Sybrecht G
    Prax Klin Pneumol; 1981 Jan; 35(1):36-41. PubMed ID: 7208408
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined administration of controlled release theophylline and ranitidine: a 53-day controlled survey in patients with chronic obstructive lung disease (COLD) and peptic disease.
    Dal Negro R; Turco P; Pomari C; Trevisan F; De Conti F; Cordaro CI
    Br J Clin Pract; 1987 Nov; 41(11):1004-8. PubMed ID: 3504314
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect and side effects of a depot theophylline preparation within the scope of a clinical trial].
    Wilke A; Weinecke A; Weide W; Schäfer K; Iwainsky H
    Z Erkr Atmungsorgane; 1986; 167(3):245-53. PubMed ID: 3551350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Optimizing of therapy with theophylline preparations in obstructive respiratory diseases. 4. Effect of theophylline on mucociliary clearance and maximal inspiratory mouth occlusion pressure].
    Schmidt G; Ranke C; Creutzig H; Oellerich M; Sybrecht GW
    Prax Klin Pneumol; 1983 Apr; 37(4):154-60. PubMed ID: 6866926
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of theophylline-ethylenediamine in obstructive lung disease (author's transl)].
    Brossmann D; Ruf G; Wiessmann KJ
    Dtsch Med Wochenschr; 1980 Mar; 105(12):410-3. PubMed ID: 7363785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of theophylline in slow-release or regular preparations in chronic obstructive lung disease. A double-blind study comparing Nuelin Depot, Nuelin and placebo].
    Aamodt T; Lien JT; Haaversen O; Osmundsen K
    Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1397-9. PubMed ID: 6353660
    [No Abstract]   [Full Text] [Related]  

  • 34. Slow release salbutamol and Tedral in the treatment of reversible airways obstruction.
    Lal S; Bhalla KK; Davey AJ
    Postgrad Med J; 1971 Mar; 47():Suppl:89-92. PubMed ID: 4929401
    [No Abstract]   [Full Text] [Related]  

  • 35. [Controlled treatment with a retard theophylline preparation].
    Wilke A; Iwainsky H; Kulpe K
    Prax Klin Pneumol; 1988 Jul; 42(7):603-5. PubMed ID: 3186668
    [No Abstract]   [Full Text] [Related]  

  • 36. [Theophylline in the therapy of non reversible airway obstruction].
    Drigo R; Bevilacqua M; Franco R
    G Clin Med; 1987 Jan; 68(1):39-45. PubMed ID: 3301490
    [No Abstract]   [Full Text] [Related]  

  • 37. [Individual theophylline doses following ambulatory determination of theophylline clearance].
    Harder S; Staib AH; Stauder J
    Prax Klin Pneumol; 1986 Aug; 40(8):334-8. PubMed ID: 3748986
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical study of theophyllinemia in patients with obstructive bronchial syndrome].
    Vasiliev CB; Burnea D; Vasiliev R; Popescu C; Anastasatu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(2):169-80. PubMed ID: 6316471
    [No Abstract]   [Full Text] [Related]  

  • 39. [Increase of arterial oxygen pressure in therapy with theophylline in patients with obstructive ventilation disorder and partial respiratory insufficiency].
    Schmidt EW; Ulmer WT
    Prax Klin Pneumol; 1988 Jul; 42(7):600-2. PubMed ID: 3054862
    [No Abstract]   [Full Text] [Related]  

  • 40. [Theophylline--once or twice daily?].
    Schoch C; Menz G; Virchow C
    Fortschr Med; 1987 May; 105(16):319-22. PubMed ID: 3301601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.